Piezo1 Knockout Improves Post-Stroke Cognitive Dysfunction by Inhibiting the Interleukin-6 (IL-6)/Glutathione Peroxidase 4 (GPX4) Pathway
DOI: https://doi.org/10.2147/jir.s448903
IF: 4.5
2024-04-13
Journal of Inflammation Research
Abstract:Lujia Tang, &ast Di Xie, &ast Shangyuan Wang, Chengjin Gao, Shuming Pan Department of Emergency, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shuming Pan; Chengjin Gao, Email ; Background: Cerebral infarction often results in post-stroke cognitive impairment, which impairs the quality of life and causes long-term disability. Astrocytes, the most abundant glial cells in the central nervous system, have a crucial role in cerebral ischemia and neuroinflammation. We explored the possible advantages of interleukin-6 (IL-6), a powerful pro-inflammatory cytokine produced by astrocytes, for post-stroke cognitive function. Methods: Mendelian randomization was applied to analyze the GWAS database of stroke patients, obtaining a causal relationship between IL-6 and stroke. Further validation of this relationship and its mechanisms was conducted. Using a mouse model of cerebral infarction, we demonstrated a significant increase in IL-6 expression in astrocytes surrounding the ischemic lesion. This protective effect of Piezo1 knockout was attributed to the downregulation of matrix metalloproteinases and upregulation of tight junction proteins, such as occludin and zonula occludens-1 (ZO-1). Results: Two-step Mendelian randomization revealed that IL-6 exposure is a risk factor for stroke. Moreover, we conducted behavioral assessments and observed that Piezo1 knockout mice that received intranasal administration of astrocyte-derived IL-6 showed notable improvement in cognitive function compared to control mice. This enhancement was associated with reduced neuronal cell death and suppressed astrocyte activation, preserving ZO-1. Conclusion: Our study shows that astrocyte-derived IL-6 causes cognitive decline after stroke by protecting the blood-brain barrier. This suggests that piezo1 knockout may reduce cognitive impairment after brain ischemia. Further research on the mechanisms and IL-6 delivery methods may lead to new therapies for post-stroke cognition. Keywords: cerebral infarction, neuroinflammation, astrocytes, blood-brain barrier, tight junctions Cerebral infarction, commonly referred to as a stroke, is a leading cause of cognitive dysfunction worldwide. The pathophysiology of cognitive impairment following cerebral infarction is multifactorial, involving various cellular and molecular mechanisms. Amongst the key players in this process are astrocytes, the most abundant glial cells in the central nervous system. 1,2 Astrocytes are crucial for maintaining brain homeostasis and supporting neuronal function. However, following cerebral infarction, they undergo phenotypic changes, becoming reactive astrocytes. Reactive astrocytes release inflammatory cytokines, chemokines, and reactive oxygen species, contributing to neuroinflammation and exacerbating neuronal damage. 3,4 The role of astrocytes in cognitive impairment has gained increasing recognition in recent years. Astrocytes are a type of glial cell that provide support and nourishment to neurons in the brain. While traditionally viewed as primarily supportive cells, emerging evidence has revealed their active involvement in cognitive processes. Astrocytes play a critical role in maintaining the integrity of the blood-brain barrier (BBB), a highly selective barrier that regulates the entry of substances into the brain. Dysfunction of the BBB has been implicated in various cognitive disorders, including Alzheimer's disease. 5 Astrocytes contribute to BBB maintenance by forming end-feet processes that surround the blood vessels and release molecules that regulate the permeability of the barrier. In addition to their role in the BBB, astrocytes are involved in neurotransmitter balance and synaptic transmission. They regulate the levels of important neurotransmitters, such as glutamate and gamma-aminobutyric acid (GABA), which are crucial for cognitive functions, including learning and memory. 6 Dysregulation of astrocytic glutamate uptake, for example, has been implicated in neurodegenerative diseases and cognitive impairments. Astrocytes secrete neurotrophic factors and neuroprotective molecules, promoting neuronal survival and regeneration. Additionally, they contribute to the clearance of neuronal metabolic waste and regulate neuronal activity, maintaining the stability of neural circuits. In conclusion, astrocytes play a dual role in the context of cerebral infarction and cognitive dysfunction. On one hand, activated astrocytes exacerbate brain damage and contribute to cognitive impairment through their inflammatory response. However, the mechanism by which Piezo1 c -Abstract Truncated-
immunology